As part of Pulmonary Hypertension Awareness Month, the Pulmonary Hypertension Association (PHA) sets aside a special day, this year on Nov. 13, to help raise awareness and improve diagnosis of a rare form of pulmonary hypertension (PH) known as chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a form of PH caused by old blood clots, also known as pulmonary emboli, in the lungs. If left untreated, CTEPH can be deadly. The good news is that CTEPH patients have unique surgical and treatment options.
Join PHA as we spread awareness about this disease all day long on Nov. 13, with special events, resources and social media activities such as:
- Ask the Expert About CTEPH: A CTEPH Awareness Day Facebook Live Q&A at 1:30 p.m. E.S.T. with CTEPH expert Peter Hountras, M.D., from UC Health University of Colorado Hospital.
Also, inspiring stories by individuals with CTEPH are available throughout the month through PHA’s “PHaces of Hope” campaign, which involves a community of individuals with PH, caregivers and health care professionals who share what gives them hope while facing a potentially deadly disease.
The day’s activities can also be followed on social media using #CTEPHDay. PHA is grateful to Bayer for its sponsorship of CTEPH Awareness Day activities. Check out our free resources on CTEPH Awareness Day at: PHAssociation.org/CTEPHDay.
